Pilot Study to prove the reproducibility of the intestinal environment of PMAS System through the production of Equol after intake of Soy Isoflavone

Pilot Study to prove the reproducibility of the intestinal environment of PMAS(Pharmaceutical Meta-Analytical Screening) System through the production of Equol after intake of Soy Isoflavone

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008816

Enrollment

Registered

2023-09-22

Start date

2023-05-23

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : This study was conducted using a single-group design. Participants were instructed to consume Soy Isoflavones in the form of capsules. Each capsule contained 60 mg of isoflavones.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Healthy adults who are 19 years of age or older. 2. Individuals who have willingly and voluntarily agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Individuals who have a hypersensitivity or allergy to soy materials, such as soy isoflavones. 2. Individuals who have been determined by the tester to be unsuitable for participation in the human application test. 3. Individuals who have used systemic antibiotics within one week prior to Visit 1. 4. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
The conformity between equol generators and non-generators was confirmed based on the results obtained from both human application tests and PMAS (Pharmaceutical Meta-Analytical Screening).	—

Secondary

Measure	Time frame
It can be confirmed through medical examination, physical examination, and adverse reaction evaluation conducted at the time of visit.	—

Countries

Korea, Republic of

Contacts

Public ContactHyun Jin Ku

boazmedical

kuhj1229@handong.edu+82-54-260-3022

Outcome results